Sangamo Therapeutics
SGMO
#10512
Rank
A$30.03 M
Marketcap
A$0.07250
Share price
0.00%
Change (1 day)
-91.23%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.11 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are A$0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.12 B4.79%
2023-12-31A$0.12 B-69.23%
2022-12-31A$0.39 B-17.76%
2021-12-31A$0.47 B-16.68%
2020-12-31A$0.57 B96.17%
2019-12-31A$0.29 B-7.66%
2018-12-31A$0.31 B150.18%
2017-12-31A$0.12 B320.63%
2016-12-31A$30.09 M-11.57%
2015-12-31A$34.03 M-23.85%
2014-12-31A$44.69 M108.43%
2013-12-31A$21.44 M26.35%
2012-12-31A$16.97 M141.56%
2011-12-31A$7.02 M0.63%
2010-12-31A$6.98 M-59.94%
2009-12-31A$17.42 M-1.26%
2008-12-31A$17.65 M31.03%
2007-12-31A$13.47 M50.1%
2006-12-31A$8.97 M-41.2%
2005-12-31A$15.26 M403.08%
2004-12-31A$3.03 M43.56%
2003-12-31A$2.11 M-39.89%
2002-12-31A$3.51 M-32.74%
2001-12-31A$5.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$173.57 B 145,176.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$120.80 B 101,009.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$15.70 B 13,044.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
A$62.37 B 52,105.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$47.62 B 39,762.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$119.99 B 100,329.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$5.87 B 4,820.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$3.44 B 2,787.03%๐Ÿ‡บ๐Ÿ‡ธ USA